Devicemakers Comment on Machine Learning for SaMD

A combination of real-world evidence and periodic reporting to the FDA should be the cornerstone of how the agency regulates AI and machine learning in software as a medical device, Philips said in a comment on the agency’s draft framework document.
Source: The GMP Letter